SEC Company Response from Scinai Immunotherapeutics Ltd. (SCNI) (CIK 0001611747) (SCNI) — May 1, 2015
Scinai Immunotherapeutics Ltd. (SCNI) (CIK 0001611747)
Date: May 1, 2015 · CIK: 0001611747 · Accession: 0001213900-15-003182
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-201283
Letter
Attention: Matthew Jones Registration Statement on Form F-1 Filed April 30, 2015 File No. 333-201283
Re: Biondvax Pharmaceuticals Ltd.
Dear Mr. Jones:
The undersigned, being the Registrant identified in Registration Statement No. 333-201283 requests to cancel its acceleration request submitted to the Securities and Exchange Commission on April 28, 2015.
Very truly yours,
/s/ Ron Babecoff
Show Raw Text
CORRESP
1
filename1.htm
May 1, 2015
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-4561
Attention: Matthew Jones
Re:
Biondvax Pharmaceuticals Ltd.
Registration Statement
on Form F-1
Filed April 30, 2015
File No. 333-201283
Dear Mr. Jones:
The undersigned, being
the Registrant identified in Registration Statement No. 333-201283 requests to cancel its acceleration request submitted to the
Securities and Exchange Commission on April 28, 2015.
Very truly yours,
/s/ Ron Babecoff
Ron Babecoff
Chief Executive Officer